SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-17-041879
Filing Date
2017-06-27
Accepted
2017-06-27 19:41:51
Documents
2
Period of Report
2017-06-27

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 5148
2 EX-24 ex-24.htm EX-24 9762
  Complete submission text file 0001104659-17-041879.txt   16299
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Issuer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Kaufman Michael J. (Reporting) CIK: 0001709996 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38129 | Film No.: 17933489